Xenon Pharmaceuticals Inc Cash Flow Quality Index

Latest as of December 2014: -2.41x

Xenon Pharmaceuticals Inc cash flow quality index. Xenon Pharmaceuticals Inc (XENE) has a Cash Flow Quality Index of -2.41x as of December 2014. Operating cash flow of $-2.95 Million is below net income of $1.22 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore debt repayment capacity of Xenon Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-2.41x
Operating CF / Net Income

Operating Cash Flow

$-2.95 Million
USD

Net Income

$1.22 Million
USD

Data as of

Dec 2014
Most recent filing

Cash Flow Quality Index of Xenon Pharmaceuticals Inc (2013–2014)

Cash flow quality index of Xenon Pharmaceuticals Inc from 2013 to 2014. Historical Cash Flow Quality Index for Xenon Pharmaceuticals Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Xenon Pharmaceuticals Inc balance sheet independence to measure how much of total assets are equity-financed.

Xenon Pharmaceuticals Inc Cash Flow Quality Index by Year (2013–2014)

Xenon Pharmaceuticals Inc cash flow quality index by year from 2013 to 2014. Year-by-year earnings quality comparison for Xenon Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash flow conversion of Xenon Pharmaceuticals Inc.

Year Quality Index Operating CF (USD) Net Income YoY Change
2014 0.02x $266.00K $13.02 Million ▲ +107.4%
2013 -0.28x $-3.32 Million $12.03 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.